A21V (p.Ala21Val) variant of PCSK1 (Neuroendocrine convertase 1)
A21V (p.Ala21Val) in PCSK1 (Neuroendocrine convertase 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
A21V (p.Ala21Val) variant details
- p.Ala21Val
- NCI-TCGA Cosmic COSV6073
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.15
- MetaSVM -0.96
- SIFT 0.55
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available